If you have been reading about c-Met receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-08-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
| Property | Value | Notes |
|---|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Common full name in research literature. |
| Class | Synthetic peptide | Modified angiotensin IV analog. |
| Related compound | Angiotensin IV | Parent peptide fragment. |
| Proposed target | HGF/c-Met pathway | Described as an HGF mimetic; not fully confirmed. |
| Development status | Preclinical research | No widely approved clinical use. |
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
two DNA primers that are complementary to the 3' (three prime) ends of each of the sense and anti-sense strands of the DNA target (DNA polymerase can only bind to and elongate from a double-stranded region of DNA; without primers, there is no double-stranded initiation site at which the polymerase can bind); specific primers that are complementary to the DNA target region are selected beforehand, and are often custom-made in a laboratory or purchased from commercial biochemical suppliers deoxynucleoside triphosphates, or dNTPs, the building blocks from which the DNA polymerase synthesizes a new DNA strand a buffer solution providing a suitable chemical environment for optimum activity and stability of the DNA polymerase bivalent cations, typically magnesium (Mg) or manganese (Mn) ions; Mg2+ is the most common, but Mn2+ can be used for PCR-mediated DNA mutagenesis, as a higher Mn2+ concentration increases the error rate during DNA synthesis; and monovalent cations, typically potassium (K) ions The reaction is commonly carried out in a volume of 10–200 μL in small reaction tubes (0.2–0.5 mL volumes) in a thermal cycler. The thermal cycler heats and cools the reaction tubes to achieve the temperatures required at each step of the reaction (see below). Many modern thermal cyclers make use of a Peltier device, which permits both heating and cooling of the block holding the PCR tubes simply by reversing the device's electric current. Thin-walled reaction tubes permit favorable thermal conductivity to allow for rapid thermal equilibrium.
== Surveillance == Comparitech Limited, a UK technology advisor, published "The world's most-surveilled cities" in August 2019. It assembled data on the number of closed-circuit television (CCTV) cameras installed in 120 global cities. It then ranked the cities by number of cameras per 1,000 inhabitants. China's cities were found to be the most surveilled. Bangkok was ranked 31 (1=most surveilled; 120=least surveilled), with an estimated 53,429 cameras installed, or 5.16 cameras per 1,000 inhabitants. Other ASEAN cities were ranked: Singapore, 11 (86,000 cameras); Ho Chi Minh City, 72 (6,150 cameras); Yangon, 76 (2,995 cameras); Jakarta, 77 (6,000 cameras); Hanoi, 79 (4,400 cameras); Kuala Lumpur, 106, (1,000 cameras).
=== Demineralization === In the strict sense, the term demineralization should imply removing all dissolved "mineral species" from water. Thus not only removing dissolved salt as obtained by simple deionization, but also neutral dissolved "Mineral species" such as dissolved iron hydroxides (Fe(OH)3) or dissolved silica (Si(OH)4), two solutes often present in water. In this way, demineralized water has the same electrical conductivity as deionized water, but is purer because it does not contain non-ionized substances, i.e. neutral solutes. However, demineralized water is often used interchangeably with deionized water and can be also confused with softened water, depending on the exact definition used: removing only the cations susceptible to precipitate as insoluble minerals (from there, "demineralization"), or removing all the "mineral species" present in water, and thus not only dissolved ions but also neutral solute species. So, the term demineralized water is vague and deionized water or softened water should often be preferred in its place for more clarity.
{\displaystyle u_{\mathrm {r} }(n_{\mathrm {A} })_{\mathrm {min} }\mapsto \partial \left({\frac {(R_{\mathrm {A} }-R_{\mathrm {B} })}{(R_{\mathrm {A} }-R_{\mathrm {AB} })(R_{\mathrm {AB} }-R_{\mathrm {B} })}}R_{\mathrm {AB} }\right)/\partial R_{\mathrm {AB} }=0}
Sources: en.wikipedia.org
== Lord's Resistance Army insurgency == The United States had been involved clandestinely in the Lord's Resistance Army insurgency since at least 2008; President Barack Obama deployed forces here in October 2011, the deployment is known as Operation Observant Compass. In March 2017, NBC News reported that Green Berets have been ordered to "apprehend or remove" Joseph Kony, one of the world's most notorious warlords from the battlefield, along with his top commanders. With about 80 military personnel and several dozen support personnel they were tasked with finding around 150 LRA fighters in an area of operations the size of California; carrying out missions (specifically patrols) in the Central African Republic, Democratic Republic of the Congo, South Sudan and Uganda. The cooperation between U.S. special forces and the UPDF has led to notable successes: In January 2015, Green Berets were present after Dominic Ongwen turned himself in to authorities; previously in October 2012, an Invisible Children, Inc. program that encourages defections from the group and the rehabilitation of former fighters and escaped abductees resulted in notable defections, including several bodyguards; the LRA's "chief intelligence officer" who walked for four days from Sudan into CAR, was handed over to the UPDF with U.S. special forces present. LtCol Matt Maybouer, the commander of the operation said that "U.S. soldiers are not engaged in direct combat;" Green Beret teams conducting patrols carryout zone reconnaissance: a coordinated search for recent LRA activity.
== Career == After her PhD, Chutia continued her research at Dibrugarh University for another year as a CSIR-postdoctoral fellow. She entered the field of plasma physics at the Physical Research Laboratory in Ahmedabad and then joined the Institute for Plasma Research in Gandhinagar. She then returned to the Institute of Advanced Study in Science and Technology as a faculty member and set up the Plasma Physics Laboratory. After finishing a fellowship awarded by the Japanese government in 1988 to work at the Plasma Laboratory of the Institute of Space and Astronautical Science, Tokyo, in 2005 she became the director of the Institute of Advanced Study in Science and Technology.
== Commercial production == Production of nicotinamide mononucleotide in the United States as a dietary supplement was prohibited in 2022 by the FDA because it is under investigation as a pharmaceutical drug. The FDA has now rescinded this determination for the β-NMN form.
==== Platelet-rich plasma ==== The effectiveness of injections of platelet-rich plasma (PRP) is unclear; there are suggestions that such injections improve function but not pain, and are associated with increased risk. A 2014 Cochrane review of studies involving PRP found the evidence to be insufficient.
== Toxicity == All Datura plants contain tropane alkaloids such as scopolamine and atropine, primarily in their seeds and flowers, as well as the roots of certain species such as D. wrightii. Because of the presence of these substances, Datura has been used for centuries in some cultures as a poison. A given plant's toxicity depends on its age, where it is growing, and the local weather conditions. These variations make Datura exceptionally hazardous as a drug. Since datura directly causes the effects of anticholinergic syndrome, the symptoms of its toxicity are often cited by the traditional mnemonic: "Blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone, the bowel and bladder lose their tone, and the heart runs alone". Datura, as well as long-term psychoactive/toxic usage of other anticholinergic drugs, also appear to significantly increase the risk of developing dementia. In traditional cultures, a great deal of experience with and detailed knowledge of Datura was critical to minimize harm. Many tragic incidents result from modern users ingesting or smoking Datura. For example, in the 1990s and 2000s, the United States media reported stories of adolescents and young adults dying or becoming seriously ill from intentionally ingesting Datura. Deliberate or inadvertent poisoning resulting from smoking jimsonweed and other related species has been reported as well. Although most poisonings occur with more common species of Datura such as D. stramonium, several reports in the medical literature indicate deaths from D. ferox intoxication.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.
No, dihexa is a synthetic compound derived from the structure of angiotensin IV. Angiotensin IV occurs naturally, but dihexa has modifications that change its properties. It is not a standard dietary component.
The main hypothesis is that dihexa interacts with the hepatocyte growth factor system, possibly through c-Met signaling. This interaction may influence synaptogenesis and neuronal plasticity. The exact molecular target remains an active area of study.
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.